openPR Logo
Press release

T&T Scientific Launches the World’s Best Manufacturing Platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines

10-01-2021 02:09 PM CET | Science & Education

Press release from: T&T Scientific Corp.

Lipid Nanoparticle

Lipid Nanoparticle

On Sep 27th, Nima Tamaddoni, the CEO at T&T Scientific announces its revolutionary manufacturing platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines such as COVID-19 vaccines.

The Chief Executive Officer at T&T Scientific, Dr. Nima Tamaddoni, made this announcement live. He emphasized: "It is a true honor and pleasure to push the NanoSizer FLOW GMP to the finish line and launch it. We started this platform to help millions of people reaching lifesaving gene therapeutics and vaccines the fastest with the highest quality and lowest cost possible. Either you are a small company or a large pharmaceutical manufacturer, or a formulation company, this platform provides a reliable, low-cost, high quality, high throughput solution in a very high range (100mL-500L+) of operation for the cGMP manufacturing of therapeutics and vaccines nanomedicines. We believe this is truly, and precisely the best nanomedicine manufacturing technology in the market. The team at T&T Scientific is excited to contribute to saving lives by preventing and curing diseases with novel gene therapeutics and vaccines. This technology specifically and precisely adds value to the market to help the entire world access much-needed lifesaving disease prevention and treatments. Big thanks to our team and everyone involved in this technology that puts significant time and cares into getting to this point.". Some of the clear competitive advantages can be listed as below:
• No String Attached: Customers and clients do not pay licensing or royalty fees for purchasing
• Scalable in a Wide Range: It covers high scale processing with the smallest footprint unit from 100mL to 500L+ (Continuous and Batch Modes)
• Low Cost: Significantly Lower Cost
• High Quality: Low PDI and High Encapsulation Efficiency (EE%)
• Quality Control Options: Pressure and Flow Rate Measurement
• Small Footprint and Bench Top
• Post-processing Tangential Flow Filtration (TFF) and Sterile Filtration Compatible

Alex Aust, MS, MBA, the director of business development at T&T Scientific, then presented live the demonstration of the technology with mRNA LNP production, which can be seen at:
https://www.youtube.com/watch?v=XgPC-95Z24U
T&T Scientific's future effort is to complete this technology with whole downstream filtration, including tangential flow filtration and downstream sterile filtration into fill and finish technologies, all in a closed system. T&T also offers services for contract development and manufacturing services from preclinical to commercial manufacturing.

Contact Name: Nima Tamaddoni, Ph.D.,
Company name: T&T Scientific Corp.
- Email address: Nima@ttscientific.com
URL: www.ttscientific.com/flow

It is important to note that T&T technology comes with full quality validation and qualification packages for GMP operation, and no royalty or licensing is required for customers to pay at any time. Once the unit is purchased, it will be all yours. This is a clear and competitive advantage to help the world use these systems anywhere from small to large pharmaceutical laboratories and manufacturing lines to site fields in Africa. This system can be set up, qualified, and validated for much-needed manufacturing of lifesaving therapeutics and vaccines.

YouTube link: https://www.youtube.com/watch?v=XgPC-95Z24U

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release T&T Scientific Launches the World’s Best Manufacturing Platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines here

News-ID: 2414418 • Views:

More Releases for Lipid

Business Research of Lipid Disorder Treatment
The global lipid disorders treatment market is estimated to grow at a significant rate, states Transparency Market Research, in its recent report. The analysis on lipid disorders projects the market of lipid disorder treatment is likely to reach around worth of US$40 bn by the end of year 2026. Development of the global market is pushed by advancement in the treatment for lipid digestion disorders. Read Report Overview - https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html Organizations associated
Lipid Nanoparticles, Key Component of COVID-19 mRNA Vaccines
Lipid nanoparticles have been developed as vehicles for small molecule delivery by the nanomedicine and materials communities and are now a key component of COVID-19 mRNA vaccines. Vaccines against COVID-19 have been developed with unprecedented speed. In particular, mRNA vaccines — a technology already in clinical trials for other infectious diseases, such as influenza — have shown impressive efficacy in clinical trials.  mRNA vaccines rely on the delivery of mRNA into the
Lipid Nutrition Market Size & Analysis - Forecasts to 2026
The results evaluated by GME suggested that by 2026, the Global Lipid Nutrition Market will grow with a 9.1 percent CAGR from 2021 to 2026. The growing availability of a vegan source of lipid nutrition along with the increasing occurrence of natural products will boost the outlook for the industry in the forthcoming years. Browse 157 Market Data Tables and 117 Figures spread through 187 Pages and in-depth TOC on "Global
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Coated Bead Products - Exclusive Tools From Echelon for Protein-Lipid Inte …
MoBiTec's partner company Echelon Biosciences, USA, is excited to introduce a new class of lipid microparticles small enough to be used in phagocytosis experiments! Phosphatidylserine (PS), Phosphatidylcholine (PC), and PC/PS microparticles have phospholipids attached in a unique way allowing headgroups to be exposed and available for the study of biological interactions. Their size, approximately 3 µm, are ideal for phagocytosis and accommodates analysis with standard flow cytometry and microscopy methods. Lipid
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider